# 2026-14707: FDA Seeks Comments on Medical Device Notifications

2026-14707, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Notifications Submission, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-07-22, effective Submit written comments (including recommendations) on the collection of information by August 21, 2026. (as of 2026-07-29).

- Canonical: https://policyrisk.com/federal-register/2026-14707
- As of: 2026-07-29
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-14707
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Notifications Submission
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 46123
- Published: 2026-07-22
- Effective: Submit written comments (including recommendations) on the collection of information by August 21, 2026.
- Comments close: 2026-08-21
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-07-29

## In one line

FDA Seeks Comments on Medical Device Notifications

## Summary

The FDA is asking for approval to keep collecting info from companies that want to sell certain medical devices. If you plan to market a device that doesn’t need full approval, you must send a premarket notification at least 90 days before selling it. Comments on this process are open until August 21, 2026, so now’s the time to speak up!

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27
- [2026-20727](https://policyrisk.com/federal-register/2026-20727): Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorgani…, 2026-10-09

## Sources
- [2026-14707 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/22/2026-14707/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-14707 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-22/pdf/2026-14707.pdf)

## Related
- [Previous: 2026-14706, Notice of OFAC Sanctions Action](https://policyrisk.com/federal-register/2026-14706)
- [Next: 2026-14708, Agency Information Collection Activities; Submission to the Office of Managemen…](https://policyrisk.com/federal-register/2026-14708)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-14707 (as of 2026-07-29).